Endava ADRs On Track for Record Low Close on Outlook Cut, 3Q Revenue Miss

Dow Jones
Yesterday
 

By Kelly Cloonan

 

American depository receipts of Endava fell after the company lowered its outlook for the full year and logged lower-than-expected revenue in the fiscal third quarter.

ADRs fell 29% to $15.27 on Wednesday, on track to close at a new all-time low. ADRs have declined 49% over the past 12 months.

Earlier Wednesday, the London-based company guided for full-year revenue growth of 6% to 6.5% on a constant currency basis, and adjusted earnings per share of 1.11 British pounds ($1.48) to GBP1.13, down from its previous guidance for sales to grow 8.5% to 9.0% and adjusted earnings of GBP1.20 to GBP1.23 per share.

Analysts polled by FactSet were looking for sales growth of 6.6% and adjusted earnings of GBP1.18.

For the fiscal third quarter, the technology services company posted a profit of GBP10.9 million, or GBP0.18 a share, compared with a loss of GBP1.7 million, or GBP0.03 a share, a year earlier.

Adjusted earnings per share were GBP0.34, ahead of estimates of GBP0.30 a share, according to analysts polled by FactSet.

Revenue rose 12% to GBP194.8 million, missing analyst estimates for sales of GBP197.6 million and the company's own previous guidance.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

May 14, 2025 11:41 ET (15:41 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10